Literature DB >> 23106384

Rivaroxaban prevents painful cutaneous infarctions in livedoid vasculopathy.

N Kerk, A Drabik, T A Luger, S W Schneider, T Goerge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23106384     DOI： 10.1111/bjd.12100

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  3 in total

1.  Successful treatment of livedoid vasculopathy with rivaroxaban.

Authors:  John M Evans; J Daniel Jensen; Naveed Sami
Journal:  JAAD Case Rep       Date:  2015-09-24

2.  Treatment application of rivaroxaban in Chinese patients with livedoid vasculopathy.

Authors:  Wenji Chen; Lina Fan; Yanyan Wang; Xiaohu Deng
Journal:  J Pain Res       Date:  2017-03-17       Impact factor: 3.133

Review 3.  Livedoid vasculopathy: A multidisciplinary clinical approach to diagnosis and management.

Authors:  Asli Bilgic; Salih Ozcobanoglu; Burcin Cansu Bozca; Erkan Alpsoy
Journal:  Int J Womens Dermatol       Date:  2021-09-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.